Skip to content

Clinical Study of "Wushen Acupuncture" Combined with the Chinese Medicine Master ZHANG Lei's Mian'an Decoction in Treatment of Compound Types Insomnia

Clinical Study of "Wushen Acupuncture" Combined with the Chinese Medicine Master ZHANG Lei's Mian'an Decoction in Treatment of Compound Types Insomnia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001749
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Wushen acupuncture combined with the Chinese Medicine Master ZHANG Lei's Mian'an decoction group:The treatment method is the combined application of "Wushen Acupuncture"and Chinese Medicine Master ZHA
waiting for treatment group:The subjects in this group will not receive any treatment and will be under observation for 2 weeks. After the trial the research team will provide them with a 2-week treat
"Wushen Acupuncture" group:"Wushen Acupuncture"involves needling at Baihui (GV20), Sishencong (EX-HN1), Shenmen (HT7), Neiguan (PC6), Sanyinjiao (SP6), Zusanli (ST36), and Fenglong (ST40).The treatmen

Sponsors

Third Affiliated Hospital of Henan University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Consistent with the diagnostic criteria of both traditional Chinese medicine and Western medicine; (2) It is necessary to simultaneously present the above two TCM syndrome types of insomnia; (3) Patients are aged between 18 and 70 years old regardless of gender; (4) No medications for the treatment of insomnia have been taken and no other treatments have been received in the past week; (5) Voluntarily join this trial and sign the Informed Consent Form for participating in the trial.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) Individuals with ulceration or infection at the acupuncture site; (3) Those currently participating in other clinical trials; (4) Individuals with drug or alcohol abuse or dependence; (5) Those with mental illnesses or cognitive dysfunction; (6) Individuals complicated with tumors severe cardiovascular and cerebrovascular diseases hepatic and renal dysfunction coagulation dysfunction severe respiratory diseases or extreme physical debility.

Design outcomes

Primary

MeasureTime frame
Pittsburgh sleep quality index;

Secondary

MeasureTime frame
Montreal Cognitive Assessment scale;Self-Rating Anxiety Scale;Polysomnography;Motilin;Gastrin;5-hydroxytryptamine;Brain-derived neurotrophic factor;

Countries

China

Contacts

Public ContactFeng Wanzhen

Third Affiliated Hospital of Henan University of traditional Chinese Medicine

wzzz2001@163.com18749597762

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026